Home Newsfeeds Biden Tweets: ‘I am determined to ban assault weapons in this country. I did it once before, and we will do it again.’

Biden Tweets: ‘I am determined to ban assault weapons in this country. I did it once before, and we will do it again.’

https://twitter.com/POTUS/status/1564704945810673670

byBill Haddad

August 30, 2022

1 minute read

I am determined to ban assault weapons in this country.

I did it once before, and we will do it again.

— President Biden (@POTUS) August 30, 2022

Latest On Israel: Blinken, Netanyahu Shelter In Bunker During Air Raid Sirens, Pentagon Issues Warning To 2,000 US Troops

By Piero Cingari

October 16, 3:38 PM

U.S. Secretary of State Antony Blinken and Israeli Prime Minister Benjamin Netanyahu experienced a tense moment during their…

CELJF

Geron Stock Surges After Encouraging Data From Rare Blood Cancer Trial

By Vandana Singh

January 4, 10:18 AM

Geron Corporation (NASDAQ:GERN) announced topline results from its IMerge Phase 3 trial of imetelstat, in lower-risk myelodysplastic syndromes (MDS) patients who…

GERN

Kinnate Biopharma Receives Fast Track Designation From The U.S. FDA For KIN-2787, An Investigational Pan-RAF Inhibitor

By Benzinga Newsdesk

September 21, 4:07 PM

SAN FRANCISCO and SAN DIEGO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (NASDAQ:KNTE) ("Kinnate"), a clinical-stage precision oncology company, today announced that the U.S. Food and Drug

KNTE

Jim Cramer Bullish On Palantir’s Performance And Stronghold In IT Defense Industry: ‘They’ve Owned That Franchise’

By Benzinga Neuro

April 2, 4:13 AM

During the "Lightning Round" on Monday, CNBC reported that Cramer responded positively to a caller's inquiry about Palantir.

PLTR

Biden Tweets: ‘I am determined to ban assault weapons in this country. I did it once before, and we will do it again.’

Related Posts

Latest On Israel: Blinken, Netanyahu Shelter In Bunker During Air Raid Sirens, Pentagon Issues Warning To 2,000 US Troops

Geron Stock Surges After Encouraging Data From Rare Blood Cancer Trial

Kinnate Biopharma Receives Fast Track Designation From The U.S. FDA For KIN-2787, An Investigational Pan-RAF Inhibitor

Jim Cramer Bullish On Palantir’s Performance And Stronghold In IT Defense Industry: ‘They’ve Owned That Franchise’